Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 12

Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study

Total article views   HTML views PDF downloads Totals
10,195 Dovepress* 9,150+ 1,500 10,650
PubMed Central* 1,045 377 1,422
Totals 10,195 1,877 12,072
*Since 29 May 2017
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar